Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

JW Vogel, N Corriveau-Lecavalier… - Nature Reviews …, 2023 - nature.com
Neurodegenerative diseases are the most common cause of dementia. Although their
underlying molecular pathologies have been identified, there is substantial heterogeneity in …

Neuropathology and emerging biomarkers in corticobasal syndrome

S Koga, KA Josephs, I Aiba, M Yoshida… - Journal of Neurology …, 2022 - jnnp.bmj.com
Corticobasal syndrome (CBS) is a clinical syndrome characterised by progressive
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …

Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging

T Lindner, DS Bolar, E Achten, F Barkhof… - Magnetic resonance …, 2023 - Wiley Online Library
This article focuses on clinical applications of arterial spin labeling (ASL) and is part of a
wider effort from the International Society for Magnetic Resonance in Medicine (ISMRM) …

The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases

R Smith, F Capotosti, M Schain, T Ohlsson… - Nature …, 2023 - nature.com
A positron emission tomography (PET) tracer detecting α-synuclein pathology will improve
the diagnosis, and ultimately the treatment of α-synuclein-related diseases. Here we show …

Tau deposition patterns are associated with functional connectivity in primary tauopathies

N Franzmeier, M Brendel, L Beyer, L Slemann… - Nature …, 2022 - nature.com
Tau pathology is the main driver of neuronal dysfunction in 4-repeat tauopathies, including
cortico-basal degeneration and progressive supranuclear palsy. Tau is assumed to spread …

High-contrast in vivo imaging of tau pathologies in Alzheimer's and non-Alzheimer's disease tauopathies

K Tagai, M Ono, M Kubota, S Kitamura, K Takahata… - Neuron, 2021 - cell.com
A panel of radiochemicals has enabled in vivo positron emission tomography (PET) of tau
pathologies in Alzheimer's disease (AD), although sensitive detection of frontotemporal …

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains

ML Malarte, PG Gillberg, A Kumar, N Bogdanovic… - Molecular …, 2023 - nature.com
Recent mechanistic and structural studies have challenged the classical tauopathy
classification approach and revealed the complexity and heterogeneity of tau pathology in …

Tau PET imaging in neurodegenerative disorders

C Groot, S Villeneuve, R Smith… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The advent of PET ligands that bind tau pathology has enabled the quantification and
visualization of tau pathology in aging and in Alzheimer disease (AD). There is strong …

Microglial activation and connectivity in Alzheimer disease and aging

BS Rauchmann, M Brendel, N Franzmeier… - Annals of …, 2022 - Wiley Online Library
Objective Alzheimer disease (AD) is characterized by amyloid β (Aβ) plaques and
neurofibrillary tau tangles, but increasing evidence suggests that neuroinflammation also …

Current directions in tau research: Highlights from Tau 2020

C Sexton, H Snyder, D Beher, AL Boxer… - Alzheimer's & …, 2022 - Wiley Online Library
Studies supporting a strong association between tau deposition and neuronal loss,
neurodegeneration, and cognitive decline have heightened the allure of tau and tau‐related …